Aurobindo Pharma Is One Of The Largest Players In The COVID19 Drug Associated APIs Market, According To The Business Research Company’s COVID19 Drug Associated APIs Market Global Report 2020-30: COVID-19 Growth And Change
(Companies Covered: Dr. Reddy’s Laboratories, Lianyungang Guike Pharmaceutical, Alembic Pharmaceutical, Wockhardt Ltd, Sandoz Srl, Lupin Limited, Aurobindo Pharma Ltd., Shanghai Shyndec Pharmaceutical (Haimen) Co Ltd, Yatai Pharma, Zhejiang Guobang Pharmaceutical Co Ltd)
The global COVID-19 associated API market is expected to grow from $4.07 billion in 2019 to $5.11 billion by the end of 2020 at a compound annual growth rate (CAGR) of 25.6%. The growth is mainly attributed to the COVID-19 outbreak and the urgent need to treat the growing number of cases. However, with the COVID-19 cases continuously increasing, restrictive containment measures involving social distancing are enforcing the closure of industries and other commercial activities. This has an impact on all stages from production to international trade attributing to transportation and supply chain disruptions. The market is expected to reach $6.02 billion in 2023 at a CAGR of 5.6%.
Read More On The Global COVID19 Drug Associated APIs Market Report At –
The COVID19 drug-associated APIs market consists of sales of active pharmaceutical ingredients used in the manufacturing of COVID19 drugs. Active pharmaceutical ingredients are chemicals which are responsible for pharmacological activity in the human body and are used as a base in pharmaceutical drug or medicine. The APIs used for the preparation of COVID19 drugs include Azithromycin, Fentanyl, Albuterol, Cisatracurium and others.
Global COVID19 Drug Associated APIs Market Segmentation –
The COVID19 drug associated APIs market covered in this report is segmented by drug class into antimalarials, bronchodilators, antibiotics, antivirals, others.
Global COVID19 Drug Associated APIs Market Drivers –
High demand for some antiretrovirals, antimalarials, sedatives, bronchodilators, and other respiratory drugs drives the demand for the active pharmaceutical ingredients (APIs) used in the production of COVID19 drugs. Active pharmaceutical ingredients (APIs) are the biologically active component used in manufacturing pharmaceutical drugs. Remdesivir and Favipiravir are two common antiviral medications currently being used for the treatment of COVID19 patients.
Request For A Sample Of The Global COVID19 Drug Associated APIs Market Report At –
A Few Points From The Global COVID19 Drug Associated APIs Market ToC
1. Executive Summary
2. COVID19 Drug Associated APIs Market Characteristics
3. COVID19 Drug Associated APIs Market Size And Growth
3.1. Global COVID19 Drug Associated APIs Historic Market, 2015 – 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global COVID19 Drug Associated APIs Forecast Market, 2019 – 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. COVID19 Drug Associated APIs Market Segmentation
5. COVID19 Drug Associated APIs Market Regional And Country Analysis
5.1. Global COVID19 Drug Associated APIs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global COVID19 Drug Associated APIs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
Company Name: The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 20 7193 0708
State: Greater London
Country: United Kingdom